ロード中...
Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta
Osteogenesis imperfecta (OI) is a heritable bone dysplasia characterized by increased skeletal fragility. Patients are often treated with bisphosphonates to attempt to reduce fracture risk. However, bisphosphonates reside in the skeleton for many years and long-term administration may impact bone ma...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3999166/ https://ncbi.nlm.nih.gov/pubmed/23774443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2013.06.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|